Affinia Therapeutics Inc.

CIK 1792694 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Affinia Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Oct 14, 2025D0001231919-25-000313
Dec 2, 2022RW0001193125-22-297607
Jan 4, 2022S-10001193125-22-001859
May 6, 2021D0001792694-21-000001
Mar 27, 2020D0001792694-20-000002
Nov 5, 2019D0001792694-19-000001